Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
Samuel Channon‐Wells, Ortensia Vito, Andrew McArdle, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 4, pp. e184-e199
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Updated Case Definition of MIS-C and Implications for Clinical Care
Megan Day‐Lewis, Laura Berbert, Annette Baker, et al.
PEDIATRICS (2024) Vol. 153, Iss. 2
Closed Access | Times Cited: 13
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population
Stavroula Lampidi, Despoina Maritsi, Marietta Charakida, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 4, pp. 1693-1702
Open Access | Times Cited: 5
Kawasaki disease: contemporary perspectives
Megan Day‐Lewis, Mary Beth F. Son, Mindy S. Lo
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 10, pp. 781-792
Closed Access | Times Cited: 5
An Update on Multi-System Inflammatory Syndrome in Children
Anurag Ratan Goel, Ali Yalçındağ
Current Rheumatology Reports (2025) Vol. 27, Iss. 1
Closed Access
Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C)
Phuc Huu Phan, Canh Ngoc Hoang, Ha Nguyen Thi Thu, et al.
BMJ Paediatrics Open (2025) Vol. 9, Iss. 1, pp. e003148-e003148
Open Access
Overview of COVID-19 Infection, Treatment, and Prevention in Children
Carol Kao
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 424-424
Open Access | Times Cited: 4
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
Sophya Yeoh, Diego Estrada‐Rivadeneyra, Heather Jackson, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 5, pp. 444-453
Open Access | Times Cited: 4
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry
Ashraf S. Harahsheh, Samay Shah, Frédéric Dallaire, et al.
Canadian Journal of Cardiology (2023) Vol. 40, Iss. 1, pp. 58-72
Open Access | Times Cited: 10
SARS-CoV-2 neutralizing antibody bebtelovimab – a systematic scoping review and meta-analysis
Mabel Nyit Yi Liew, Kok Pim Kua, Shaun Wen Huey Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome (MIS-C) in Latin America: A Multicenter Observational Study of the REKAMLATINA Network
Jaime Fernández‐Sarmiento, Lorena Acevedo, Laura Fernanda Niño-Serna, et al.
Journal of Intensive Care Medicine (2024) Vol. 39, Iss. 8, pp. 785-793
Closed Access | Times Cited: 3
Should we be afraid of long-term cardiac consequences in children with multisystem inflammatory syndrome? Experience from subsequent waves of COVID-19
Katarzyna Ptak, Marta Olszewska, Izabela Szymońska, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 6, pp. 2683-2692
Closed Access | Times Cited: 3
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation
Andrea Reiter, Emely Verweyen, Emmanuelle Queste, et al.
Clinical Immunology (2024) Vol. 264, pp. 110237-110237
Open Access | Times Cited: 3
Multisystem inflammatory syndrome in children: A review
Simone Benvenuto, Tadej Avčin, Andrea Taddio
Acta Paediatrica (2024) Vol. 113, Iss. 9, pp. 2011-2023
Closed Access | Times Cited: 3
Susceptibility of SARS-CoV2 infection in children
Nicola Cotugno, Donato Amodio, Danilo Buonsenso, et al.
European Journal of Pediatrics (2023) Vol. 182, Iss. 11, pp. 4851-4857
Open Access | Times Cited: 7
MIS-C Treatment: Is glucocorticoid monotherapy enough for mild cases?
Murat Sütçü, Emine Manolya Kara, Funda Yıldız, et al.
The American Journal of Emergency Medicine (2024) Vol. 83, pp. 95-100
Closed Access | Times Cited: 1
Multicenter registry of multisystem inflammatory syndrome in children (MIS-C) and Paired comparison with Kawasaki disease
Yifang Wang, Chun-Min Fu, Kun‐Lang Wu, et al.
Journal of the Formosan Medical Association (2024) Vol. 123, Iss. 11, pp. 1131-1138
Open Access | Times Cited: 1
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
Harsita Patel, Michael J. Carter, Heather Jackson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Immunoglobulin, glucocorticoid, or combined therapy for multisystem inflammatory syndrome in children
Christine Chew, Athimalaipet V Ramanan
The Lancet Rheumatology (2023) Vol. 5, Iss. 4, pp. e168-e169
Open Access | Times Cited: 4
Short-term outcomes of South African children with multisystem inflammatory syndrome in children: a prospective cohort study
Juanita Lishman, Deepthi Raju Abraham, Barend Fourie, et al.
Archives of Disease in Childhood (2023) Vol. 108, Iss. 10, pp. 792-798
Open Access | Times Cited: 3
The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study
Özge Başaran, Ezgi Deniz Batu, Ümmüşen Kaya Akça, et al.
Children (2023) Vol. 10, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 3
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial
Maya C. André, Carlos Sanchez, Sabrina Bressieux-Degueldre, et al.
EClinicalMedicine (2023) Vol. 67, pp. 102358-102358
Open Access | Times Cited: 2
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study
Archana Koirala, Jocelynne McRae, Philip N Britton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Delirium Associated with COVID-19 in Critically ill Children: An Observational Cohort Study
Meghan Gray, Chani Traube, Taylor B. Sewell, et al.
Journal of Intensive Care Medicine (2024) Vol. 39, Iss. 10, pp. 1002-1011
Closed Access
Outcome of Children with SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated with Corticosteroids: A Systematic Review and Meta-Analysis
Fereshteh Rostami-Maskopaee, Mehran Asadi-Aliabadi, Mahmood Moosazadeh, et al.
(2024)
Closed Access
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study
Archana Koirala, Jocelynne McRae, Philip N Britton, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0300555-e0300555
Open Access
Page 1 - Next Page

Scroll to top